Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

SHA:600976 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	317.8	359.84	362.18	521.46	408.08	305.26
Depreciation & Amortization	55.84	45.05	41.18	40.33	38.82	34.12
Other Amortization	26.61	26.78	29.4	18.73	15.86	15.92
Loss (Gain) From Sale of Assets	0.2	0.15	0.12	-0.68	0.02	-0.48
Asset Writedown & Restructuring Costs	-11.53	0.68	2.96	11.91	10.73	1.5
Loss (Gain) From Sale of Investments	-83.77	-137.48	-254.49	-243.27	-153.59	-123.21
Provision & Write-off of Bad Debts	17.58	17.58	44.74	3.47	10.09	5.4
Other Operating Activities	10.94	14.13	20.82	16.71	20.41	10.15
Change in Accounts Receivable	23.33	-40.58	140.3	-252.67	-302.98	3.99
Change in Inventory	-19.23	63.37	95.64	-92.82	-140.29	9.96
Change in Accounts Payable	40.39	-21.88	-261.22	258.71	299.01	4.47
Change in Other Net Operating Assets	13.41	0.12	2.44	8.85	9.44	10.27
Operating Cash Flow	339.29	274.53	234.27	268.39	215.87	247.92
Operating Cash Flow Growth	44.54%	17.19%	-12.72%	24.33%	-12.93%	97.48%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-121.15	-100.67	-120.29	-64.5	-67.96	-56.15
Sale of Property, Plant & Equipment	0.51	0.38	0.39	2.88	0.24	1.15
Divestitures	-	-	-	18.94	-	-
Investment in Securities	-179.91	-47.37	-127	-137.82	-75.47	62.38
Other Investing Activities	146.63	-	-	103.19	-	-
Investing Cash Flow	-153.92	-147.65	-246.9	-77.31	-143.2	7.38

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	103.5	45
Long-Term Debt Issued	-	85.58	154.8	79.45	3.2	10.44
Total Debt Issued	27.78	85.58	154.8	79.45	106.7	55.44
Short-Term Debt Repaid	-	-	-	-	-126	-20
Long-Term Debt Repaid	-	-119.8	-96.65	-30.2	-101.16	-2.87
Total Debt Repaid	-59.65	-119.8	-96.65	-30.2	-227.16	-22.87
Net Debt Issued (Repaid)	-31.87	-34.22	58.15	49.24	-120.46	32.57
Issuance of Common Stock	-	-	-	-	104.68	14.76
Repurchase of Common Stock	-	-	-	-	-	-38.34
Common Dividends Paid	-138.38	-141.3	-187.72	-156.2	-124.01	-58.61
Other Financing Activities	-1.37	5.78	29.02	21.26	-49.65	9.01
Financing Cash Flow	-171.62	-169.74	-100.56	-85.7	-189.44	-40.6

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	13.75	-42.86	-113.2	105.39	-116.77	214.69

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	218.14	173.86	113.98	203.89	147.9	191.77
Free Cash Flow Growth	77.13%	52.54%	-44.10%	37.85%	-22.88%	139.84%
Free Cash Flow Margin	6.87%	5.16%	3.25%	4.84%	4.06%	5.81%
Free Cash Flow Per Share	1.44	1.15	0.75	1.33	0.97	1.26
Levered Free Cash Flow	-35.25	119.23	122.08	143.06	-27.82	261.85
Unlevered Free Cash Flow	-30.33	127.47	130.17	145.37	-24.82	267.29

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	229	212.09	202.29	278.4	255.07	227.7
Change in Working Capital	5.61	-52.22	-12.64	-100.28	-134.56	-0.74

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error